SMTL ID : 4d2r.1

Human IGF in complex with a Dyrk1B inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 4 residues within 4Å: Chain A: N.143, S.274, F.275, L.276 Ligand excluded by PLIP

1 x DYK: N-{2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]phenyl}-4-(1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine(Non-covalent)

DYK.2: 14 residues within 4Å: Chain A: L.21, G.22, Q.23, V.29, E.31, A.47, E.96, L.97, M.98, T.99, R.100, G.101, M.158, M.172 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.21, A:L.21, A:V.29, A:A.47 Hydrogen bonds: A:M.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kettle, J.G. et al., Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors to Explore a Mek Resistance Hypothesis. J.Med.Chem. (2015)

Release Date

2015-04-22

Peptides

INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR